Anthracycline-based regimens are an important component of BC treatment,especially in TN BC with a high risk of recurrence (regardless of axillarylymph node involvement) and HER2−/ER+ BC with axillary lymph nodeinvolvement. The gene discussed is ERBB2; the disease is breast cancer.